- Rosenberg, S.A. (1989) "Hodgkin's disease: challenges for the future", Cancer Res. 49, 767 - 769
- Devita, Jr, V.T., Serpick, A.A. and Carbone, P.P. (1970) "Combination chemotherapy in the treatment of advanced Hodgkin's disease", Ann. Intern. Med. 73, 881 - 895
- Bonadonna, G. (1982) "Chemotherapy strategies to improve the control of Hodgkin's disease: the Richard and Hinda Rosenthal Foundation Award Lecture", Cancer Res. 42, 4309 - 4320
- Specht, L. and Nissen, N.I. (1989) "Hodgkin's disease and age", Eur. J. Haematol. 43, 127 - 135
- Fuller, L.M., Gamble, J.F., Velazquez, W.S., et al., (1980) "Evaluation of the significance of prognostic factors in stage III Hodgkin's disease treated with MOPP and radiotherapy", Cancer 45, 1352 - 1364
- Eghbali, H., Hoerni-Simon, G., de Mascarel, I., et al., (1984) "Hodgkin's disease in the elderly. A series of 30 patients aged older than 70 years", Cancer 53, 2191 - 2193
- Burgers, J.M., el Sharouni, S.Y., van Leeuwen, F.E., et al., (1988) "Hodgkin's disease: the effect of age on prognosis", Ned Tijdschr Geneeskd 132, 1354 - 1357
- Wedelin, C., Bjorkholm, M., Biberfeld, P., et al., (1984) "Prognostic factors in Hodgkin's disease with special reference to age", Cancer 53, 1202 - 1208
- Vaughan Hudson, B., MacLennan, K.A., Easterling, M.J., et al., (1983) "The prognostic significance of age in Hodgkin's disease: examination of 1500 patients (BNLI report no. 23)", Clin. Radiol. 34, 503 - 506
- Peterson, B.A., Pajak, T.F., Cooper, M.R., et al., (1982) "Effect of age on therapeutic response and survival in advanced Hodgkin's disease", Cancer Treat. Rep. 66, 889 - 898
- Tirelli, U. (1989) "Management of malignant lymphoma in the elderly. An EORTC retrospective evaluation", Acta Oncol. 28, 199 - 201
- Walker, A., Schoenfeld, E.R., Lowman, J.T., et al., (1990) "Survival of the older patient compared with the younger patient with Hodgkin's disease. Influence of histologic type, staging, and treatment", Cancer 65, 1635 - 1640
- Austin-Seymour, M.M., Hoppe, R.T., Cox, R.S., et al., (1984) "Hodgkin's disease in patients over sixty years old", Ann. Intern. Med. 100, 13 - 18
- Gobbi, P.G., Cavalli, C., Federico, M., et al., (1988) "Hodgkin's disease prognosis: a directly predictive equation", Lancet 1, 675 - 679
- Enblad, G., Glimelius, B. and Sundstrom, C. (1991) "Treatment outcome in Hodgkin's disease in patients above the age of 60: a population-based study", Ann. Oncol. 2, 297 - 302
- Kennedy, B.J., Loeb, Jr, V., Peterson, V., et al., (1992) "Survival in Hodgkin's disease by stage and age", Med. Pediatr. Oncol. 20, 100 - 104
- Glimelius, B., Enblad, G., Kalkner, M., et al., (1996) "Treatment of Hodgkin's disease: the Swedish National Care Programme experience", Leuk. Lymphoma 21, 71 - 78
- Bennett, J.M., Andersen, J.W., Begg, C.B., et al., (1993) "Age and Hodgkin's disease: the impact of competing risks and possibly salvage therapy on long term survival: an E.C.O.G. study", Leuk. Res. 17, 825 - 832
- Diaz-Pavon, J.R., Cabanillas, F., Majlis, A., et al., (1995) "Outcome of Hodgkin's disease in elderly patients", Hematol. Oncol. 13, 19 - 27
- Medeiros, L.J. and Greiner, T.C. (1995) "Hodgkin's disease", Cancer 75, 357 - 369
- Hasle, H. and Mellemgaard, A. (1993) "Hodgkin's disease diagnosed post mortem: a population based study", Br. J. Cancer 67, 185 - 189
- ErdKamp, F.L., Breed, W.P., Bosch, L.J., et al., (1992) "Hodgkin disease in the elderly. A registry-based analysis", Cancer 70, 830 - 834
- Haybittle, J.L., Hayhoe, F.G., Easterling, M.J., et al., (1985) "Review of British National Lymphoma Investigation studies of Hodgkin's disease and development of prognostic index", Lancet 1, 967 - 972
- DeVita, Jr, V.T., Simon, R.M., Hubbard, S.M., et al., (1980) "Curability of advanced Hodgkin's disease with chemotherapy. Long-term follow-up of MOPP-treated patients at the National Cancer Institute", Ann. Intern. Med. 92, 587 - 595
- Connors, J.M., Klimo, P., Adams, G., et al., (1997) "Treatment of advanced Hodgkin's disease with chemotherapy--comparison of MOPP/ABV hybrid regimen with alternating courses of MOPP and ABVD: a report from the National Cancer Institute of Canada clinical trials group", J. Clin. Oncol. 15, 1638 - 1645, published erratum appears in J. Clin. Oncol., 1997, Jul;15(7) 2762
- Kaplan, E. and Meier, P. (1958) "Nonparametric estimation from incomplete observations", J. Am. Statist. Assoc. 53, 457 - 481
- Peto, R. and Peto, J. (1972) "Asymptotically efficient rank invariant test procedures", J. Roy. Statist. Soc. 135, 185 - 207
- Bosi, A., Ponticelli, P., Casini, C., et al., (1989) "Clinical data and therapeutic approach in elderly patients with Hodgkin's disease", Haematologica 74, 463 - 473
- Lokich, J.J., Pinkus, G.S. and Moloney, W.C. (1974) "Hodgkin's disease in the elderly", Oncology 29, 484 - 500
- Hancock, B.W., Vaughan Hudson, G., Vaughan Hudson, B., et al., (1991) "British National Lymphoma Investigation randomised study of MOPP (mustine, Oncovin, procarbazine, prednisolone) against LOPP (Leukeran substituted for mustine) in advanced Hodgkin's disease--long term results", Br. J. Cancer 63, 579 - 582
- Mir, R., Anderson, J., Strauchen, J., et al., (1993) "Hodgkin disease in patients 60 years of age or older. Histologic and clinical features of advanced-stage disease. The Cancer and Leukemia Group B", Cancer 71, 1857 - 1866
- Rossi Ferrini, P., Bosi, A., Casini, C., et al., (1987) "Hodgkin's disease in the elderly: a retrospective clinicopathologic study of 61 patients aged over 60 years", Acta Haematol. 78, 163 - 170
- Canellos, G.P., Anderson, J.R., Propert, K.J., et al., (1992) "Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD", N. Engl. J. Med. 327, 1478 - 1484
- Duggan, D., Petroni, G., Johnson, J., et al., (1997) "MOPP/ABV versus ABVD for advanced Hodgkin's disease", Proc. Am. Soc. Clin. Oncol. 16 (13a)
Leukemia & Lymphoma
Volume 43, 2002 - Issue 7